Related references
Note: Only part of the references are listed.Prevention of mother-to-child transmission of multi-drug resistant HIV-1 using maternal therapy with both enfuvirtide and tipranavir
Annemarie M. J. Wensing et al.
AIDS (2006)
Genital HIV-1 viral load is correlated with blood plasma HIV-1 viral load in Brazilian women and is reduced by antiretroviral therapy
MV Vettore et al.
JOURNAL OF INFECTION (2006)
Enfurvitide prevents vertical transmission of multidrug-resistant HIV-1 in pregnancy but does not cross the placenta
P Brennan-Benson et al.
AIDS (2006)
Perinatal transmission of multidrug-resistant HIV-1 despite viral suppression on an enfuvirtide-based treatment regimen
D Cohan et al.
AIDS (2005)
Penetration of enfuvirtide, tenofovir, efavirenz, and protease inhibitors in the genital tract of HIV-1-infected men
J Ghosn et al.
AIDS (2004)
Enfuvirtide prescription at the end of pregnancy to a multi-treated HIV-infected woman with virological breakthrough
MC Meyohas et al.
AIDS (2004)
Enfuvirtide, an HIV-1 fusion inhibitor, for drug-resistant HIV infection in North and South America
JP Lalezari et al.
NEW ENGLAND JOURNAL OF MEDICINE (2003)
Efficacy of enfuvirtide in patients infected with drug-resistant HIV-1 in Europe and Australia
A Lazzarin et al.
NEW ENGLAND JOURNAL OF MEDICINE (2003)
Share Paper
